Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma industry seeks R&D sops, simplification of regulatory framework in Budget
The government should look at offering globally competitive R&D incentives and fiscal support for clinical research to the domestic pharma industry in the upcoming Budget in order to help it transform into an innovation-led $130-billion sector by…
Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal
How did American oil companies respond to the U.S. action in Venezuela? Why were Constellation investors happy with lower beer sales? Plus, can a big pharmaceutical deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana…
Smarter Compliance Support for Pharma Revenue Teams
Pharma field teams walk a tightrope every day. There is patient safety, regulatory accuracy, and brand compliance on one side. On the other, the day-to-day urgency of engaging healthcare professionals and moving conversations forward. The problem…
Cancer Drugs Drive Nearly One-Fifth Of Pharma Sales
The global pharmaceutical industry's revenue is increasingly concentrated in a handful of high-value drug classes, with oncology, diabetes/obesity treatments and immunology leading the charge. As Statista's Tristan Gaudiat details below, according…
Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma's Future
One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive amounts of data far faster than humans, identifying potential drug candidates and predicting their effects. This could cut…
Alembic Pharma's generic cancer drug Bosutinib Tablets 400 mg gets U.S. FDA nod
Alembic Pharmaceuticals has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for its generic of cancer drug Bosutinib Tablets, 400 mg. Bosutinib Tablets, 400 mg, had an estimated market size of $251 million for the…
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.5% - Time to Sell?
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) were down 6.5% during trading on Monday. The company traded as low as $31.85 and last traded at $32.1190. Approximately 400,035 shares were traded during trading, a decline…
BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 Shares
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 40,000 shares of BridgeBio Pharma stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $73.97, for a total value of $2,958,800.00.
Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Unusually-High Trading Volume - Still a Buy?
Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) saw unusually-strong trading volume on Monday. Approximately 1,480 shares changed hands during mid-day trading, an increase of 9% from the previous session's volume of 1,360 shares.The…
Ascendis Pharma A/S Touts €683M Product Revenue, Feb PDUFA Catalyst at JPM Healthcare Conference
Can BioMarin Stock Live Up to Wall Street's High Expectations? Ascendis Pharma A/S NASDAQ: ASND highlighted accelerating product revenue growth, expanding international commercialization, and multiple 2026 clinical and regulatory milestones during…
Tema Etfs LLC Sells 27,026 Shares of BridgeBio Pharma, Inc. $BBIO
Tema Etfs LLC reduced its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 21.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 96,561 shares of the…
Tucker Carlson's hollowed-out appearance sparks Ozempic rumors
Tucker Carlson 's dramatic change in appearance has sparked rumors that the hollowed-out political commentator is on a weight loss drug. Carlson, 56, was seen snapped with Florida Republican gubernatorial candidate James Fishback in a photo that…
Jim Cramer's top 10 things to watch in the stock market Monday
My top 10 things to watch Monday, Jan. 12 1. The Justice Department has opened a criminal investigation into Federal Reserve Chairman Jerome Powell. It's another apparent attempt by President Donald Trump to influence the central bank's monetary…
Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir platform.
Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir platform. San Diego, United-States and Paris, France – January 12, 2026.
Eli Lilly and Nvidia plan new AI lab to speed drug discovery
The doctor will see you now. It's an AI agent with a visitor badge — and an eight-figure monthly burn. Nvidia and Eli Lilly announced Monday that they're launching a co-innovation AI lab aimed at speeding up drug discovery — a…
Receive a Daily briefing on Pharma Industry News
Get Started